BMS-199264 is an inhibitor of F1F0 ATP hydrolase (IC50=0.5 µM) without inhibitory effect on F1F0 ATP synthase. BMS-199264 selectively inhibits ATP decline during ischemia to reduces cardiac necrosis. BMS-199264 also enhances the recovery of contractile function following reperfusion[1].
Molecular Weight:
531.07
CAS Number:
[675833-20-2]
Formula:
C26H31ClN4O4S
Target:
ATP Synthase
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
